Direct injection trial aims to shrink tough sarcoma tumors
Disease control
Recruiting now
This study is testing whether injecting an experimental drug called tigilanol tiglate directly into tumors can destroy them in people with advanced soft tissue sarcoma. The trial will enroll about 40 adults to see if the injections shrink or eliminate the treated tumors and help …
Phase: PHASE2 • Sponsor: QBiotics Group Limited • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC